Previous studies have shown that high expression of SDF-1/CXCR4 is correlated with poor survival in various tumors, such as colorectal cancer (24), prostate cancer (25), pancreatic cancer (26), and breast cancer (27). This evidence concerns the gene CXCR4 and prostate carcinoma.